Pfizer

Running trials

• Active, not recruiting

  An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis

  NCT07459686· Source

• Active, not recruiting

  A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.

  NCT07161687· Source

• Active, not recruiting

  A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

  NCT06476665· Source

• Active, not recruiting

  Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

  NCT06479954· Source

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

  NCT07527832· Source

• Completed

  RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study

  NCT06790420· Source

• Completed

  A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

  NCT05796245· Source

• Completed

  Safety and Efficacy of Trastuzumab BS

  NCT04181333· Source

• Completed

  Vyndaqel Capsules Special Investigation (ATTR-CM)

  NCT04108091· Source

• Completed

  BESPONSA Injection 1 mg Special Investigation

  NCT05923112· Source

• Completed

  Safety and Efficacy of Xalkori ROS1

  NCT03375242· Source